
CURE®’s second episode of its cooking show, Heal at Home, is here! And this time, we are bringing cancer survivors, patients and their loved ones the nutrition with a dash of holiday cheer.
Colleen Moretti, Assistant Editor for CURE®, joined MJH Life Sciences in November 2020. Colleen is a graduate of Monmouth University, where she studied communication with a focus in journalism and public relations. In her free time, she enjoys learning to cook new meals, spending time with her adopted beagle, Molly, or sitting on the beach with a good book. Email her at [email protected]
CURE®’s second episode of its cooking show, Heal at Home, is here! And this time, we are bringing cancer survivors, patients and their loved ones the nutrition with a dash of holiday cheer.
Treatment-free survival with Opdivo and Yervoy was more than twice as long when compared with Sutent alone in patients with kidney cancer.
Patients who understand their roles and responsibilities may better help their care teams understand what they may be at risk for in their cancer survivorship.
The FDA approval of Rituxan plus chemotherapy is indicated for the treatment of children aged six months to 18 years who have various forms of lymphoma or a form of leukemia.
The FDA issued a complete response letter stating there was not enough sufficient evidence that the combination demonstrated a benefit.
Catching tumors through imaging at an early stage can help guide treatment decisions and may improve a patient’s quality of life — which is why it’s important for patients to stay educated on their options.
Treatment programs that often use neoadjuvant chemotherapy as a strategy may help prolong survival in patients with advanced ovarian cancer compared with those that infrequently used the tactic, which may reassure patients and providers.
Darzalex plus Revlimid and dexamethasone may be the preferred option to treat older patients with multiple myeloma who are ineligible for stem-cell transplant.
Being informed and educated may help patients with breast cancer make a treatment decision and feel less afraid.
Radiation therapy in place of systemic therapy may improve quality of life and treatment costs for patients with renal cell carcinoma.
The approval follows statistically significant improved disease-free survival results.
The incidence of young-onset colorectal cancer has been increasing in the past years, and despite being more physically active and receiving more intense treatments, younger patients are not living longer with the disease than older patients.
This study is the first to evaluate this rising trend of pancreatic cancer incidence in women under the age of 55.
As cancer survivorship rates increase, so does a survivor’s risk for chronic conditions that may impact their quality of life.
Even though recording conversations during a doctor’s appointment may make it easier for patients with cancer to retain information, some oncologists are uncomfortable with being recorded.
Due to less travel and other treatment-related expenses, some patients with cancer prefer a telemedicine doctor’s visit over going into an office or clinic.
The majority of Americans lack understanding of lung cancer’s deadly threat and how it can be screened for, according to new survey data from the American Lung Association. One survivor and one patient stress the importance of learning more about the deadliness of the disease.
The study results demonstrated that patients with cancer had an elevated risk of all-cause mortality in the short-term if they experienced the onset of a mental health condition and were prescribed medicine for the condition shortly after their cancer diagnosis.
The Food and Drug Administration gave clearance to Bold Therapeutics for a phase 1b/2a trial examining treatments for advanced GI cancers.
Patients who experience side effects due to immune checkpoint inhibitors are 80% more likely to go to the emergency room and have 30% higher monthly medical costs, compared to patients who did not have side effects.
The FDA approval is based on ‘substantial’ disease-free survival results and may ‘drastically’ improve lung cancer survival.
Some patients with kidney cancer who are at a high risk of disease recurrence may benefit from adjuvant therapy; however, it is important recognize the potential side effects.
Lymphedema can cause swelling, discomfort and body image issues for patients with breast cancer, but nighttime compression may help reduce the effects of the complication.
Memory, attention and the ability to multitask may be affected in patients with lymphoma during and after chemotherapy treatment, which can impact one’s capability to complete daily tasks.
Medically underserved and minority breast cancer survivors experienced improved outcomes and quality of life after participating in community-based physical activity programs, according to recent study results.
Maintenance therapy with PARP inhibitors may be a beneficial option for patients with ovarian cancer after the first line of treatment.
The results, according to one of the study’s authors, indicate that liver cancer is an underrecognized and deadly cancer that is increasingly affecting people living in rural areas of the United States.
Although many women with breast cancer report being satisfied with their decision to forgo reconstruction after a mastectomy, some indicate a lack of support from their surgeon as well as limited information on their options.
Dr. Curtis Mack can relate to his patients on a level other radiation oncologists might not be able to because he has received a diagnosis, gone through treatment and survived cancer himself.
Treatments for bladder, colorectal and prostate cancer may cause sexual dysfunction in men. Here, an expert provides insight into how patients and survivors may improve their sexual health.